PTH Among Health Care ETFs
End-of-day Nov 17, 2026 · 39 Health care ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.0% | −6.7% | −2.7% | −13.6% | +11.4% | +14.5% | +86.2% | +4.2% | +277.3% | +588.4% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$43 of every $1,000 in PTH is Tenet
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | THCTenet Healthcare | Healthcare | 4.32% | $431.91 | 41K | $11.9M |
| 2 | ROIVRoivant Sciences | Healthcare | 4.23% | $423.29 | 301K | $11.6M |
| 3 | INSMInsmed | Healthcare | 4.15% | $414.98 | 93K | $11.4M |
| 4 | GHGuardant Health | Healthcare | 3.35% | $334.81 | 64K | $9.2M |
| 5 | RVMDRevolution Medicines | Healthcare | 3.34% | $333.64 | 55K | $9.2M |
| 6 | AXGNAxogen | Healthcare | 3.22% | $321.80 | 160K | $8.8M |
| 7 | HNGEHinge Health | Healthcare | 3.14% | $314.24 | 71K | $8.6M |
| 8 | MEDPMedpace | Healthcare | 3.10% | $310.07 | 13K | $8.5M |
| 9 | EXELExelixis | Healthcare | 2.86% | $286.45 | 117K | $7.9M |
| 10 | TXG10X Genomics | Healthcare | 2.86% | $286.40 | 143K | $7.9M |
| 11 | NTRANatera | Healthcare | 2.85% | $285.42 | 27K | $7.8M |
| 12 | IOVAIovance Biotherapeutics | Healthcare | 2.74% | $273.88 | 996K | $7.5M |
| 13 | CRLCharles River Laboratories International | Healthcare | 2.48% | $247.89 | 20K | $6.8M |
| 14 | CDNACareDx | Healthcare | 2.47% | $246.64 | 92K | $6.8M |
| 15 | PACSPACS Group | Healthcare | 2.39% | $238.79 | 134K | $6.6M |
of the $113B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | THC | Tenet Healthcare | 4.32% |
| 2 | ROIV | Roivant Sciences | 4.23% |
| 3 | INSM | Insmed | 4.15% |
| 4 | GH | Guardant Health | 3.35% |
| 5 | RVMD | Revolution Medicines | 3.34% |
| 6 | AXGN | Axogen | 3.22% |
| 7 | HNGE | Hinge Health | 3.14% |
| 8 | MEDP | Medpace | 3.10% |
| 9 | EXEL | Exelixis | 2.86% |
| 10 | TXG | 10X Genomics | 2.86% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 26, 2025 | $1.53 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0255 |
| Dec 20, 2013 | Dec 31, 2013 | $0.0114 |
| Sep 20, 2013 | Sep 30, 2013 | $0.0027 |
| Jun 21, 2013 | Jun 28, 2013 | $0.0368 |
| Dec 21, 2012 | Dec 31, 2012 | $0.11 |
| Jun 15, 2012 | Jun 29, 2012 | $0.0084 |
| Dec 18, 2009 | Dec 31, 2009 | $0.0194 |
| Jun 19, 2009 | Jun 30, 2009 | $0.0083 |